NSEGeneral Updates6d ago · 14 Aug 2026, 12:14 pm

General Updates

Shukra Pharmaceuticals Limited · SHUKRAPHAR

✦ AI SummaryExpansion

Shukra Pharmaceuticals Limited has informed the Exchange about General Updates, specifically the commencement of trading of its equity shares on the National Stock Exchange of India Limited (NSE) with effect from August 14, 2026.

Analysis Scores

Earnings Impact0/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Shukra Pharmaceuticals Limited has informed the Exchange about General Updates

Attachments (1)

📄

SHUKRA_14082026121343_Intimation_Reg_30_Shukra.pdf

pdf

Download →
View document text
Date: 14" August, 2026 To, To, The Listing Department The Listing Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot No. C/1, G-Block, Dalal Street, Mumbai — 400001 Bandra-Kurla Complex, Bandra (E), Mumbai — 400051 Scrip Code: 531351 Trading Symbol: SHUKRAPHAR Dear Sir/Madam, Sub.: In-timation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 — Commencement of Trading of Equity Shares of Shukra Pharmaceuticals Limited on the National Stock Exchange of India Limited (NSE) Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Equity Shares of Shukra Pharmaceuticals Limited have been listed and admitted to dealings on the Main Board of the National Stock Exchange of India Limited (NSE) with effect from today, i.e., Friday, 14th August, 2026. The trading details for the company's equity shares on NSE are as follows: a. Company Name: Shukra Pharmaceuticals Limited b. NSE Trading Symbol: SHUKRAPHAR c. ISIN: INE551C01044 d. Market Segment: Main Board — Equity The Equity Shares of the Company shall continue to be listed and traded on the BSE Limited (BSE). The base reference price on the NSE for today's trading session was determined based on the closing market price of the shares on the BSE on 13" August, 2026. This dual-listing marks a significant milestone for the Company, aimed at enhancing liquidity, expanding the investor base, and maximizing stakeholder value. We request you to kindly take the above information on your records and disseminate the same on your respective websites for the information of investors and the public. Thanking you, Yours faithfully, For Shukra Pharmaceuticals Membership No.: A80894 c|N'; 1 24231GJ1993PLC019079 Regd. Office :v3rd Floor, “VEER HOUSE” Opp. WIAA Office, Judges Bunglow Road, Bodakdev, Ahmedabad - 380 054. Factory Add. : 795, Rakanpur, Sola-Santej Road, Ta. Kalol, Dist. Gandhinagar - 382721, Gujarat, India, Ph. : 02764-286317 Email : info@shukrapharmaceuticals.com | Website : www.shukrapharmaceuticals.com